We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-15.79%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$16.4B
AUM Growth
+$4.51B
Cap. Flow
+$7.45B
Cap. Flow %
45.53%
Top 10 Hldgs %
3.04%
Holding
4,763
New
1,229
Increased
1,758
Reduced
1,274
Closed
428

Top Buys

Rank Stock Value
1
AXP icon
American Express
AXP
+$71M
2
BAC icon
Bank of America
BAC
+$53.3M
3
MPC icon
Marathon Petroleum
MPC
+$49.5M
4
ILMN icon
Illumina
ILMN
+$47.8M
5
NKE icon
Nike
NKE
+$44.9M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$43.1M
2
ZTS icon
Zoetis
ZTS
+$33.2M
3
CL icon
Colgate-Palmolive
CL
+$25.5M
4
QCOM icon
Qualcomm
QCOM
+$23.7M
5
FRC
First Republic Bank
FRC
+$23.1M

Sector Composition

Rank Sector Weight
1 Financials 15.38%
2 Technology 14.53%
3 Consumer Discretionary 10.24%
4 Healthcare 9.93%
5 Industrials 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BGSX.WS
4251
DELISTED
Build Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
BGSX.WS
$14K ﹤0.01%
+138,308
New +$28K
DNTH icon
4252
Dianthus Therapeutics
DNTH
$6.09B
$13K ﹤0.01%
+667
New +$16.5K
SNCR
4253
DELISTED
Synchronoss Technologies
SNCR
$13K ﹤0.01%
1,284
-4,513
-78% -$57.2K
NUBIW
4254
DELISTED
Nubia Brand International Corp. Warrant
NUBIW
$13K ﹤0.01%
+160,279
New +$22K
ENDP
4255
DELISTED
Endo International plc
ENDP
$13K ﹤0.01%
27,928
-630,946
-96% -$801K
TECX
4256
Tectonic Therapeutic
TECX
$606M
$12K ﹤0.01%
1,094
-781
-42% -$9.21K
TGVCW
4257
DELISTED
TG Venture Acquisition Corp. Warrants
TGVCW
$12K ﹤0.01%
100,718
– –
BNNRW
4258
DELISTED
Banner Acquisition Corp. Warrants
BNNRW
$12K ﹤0.01%
110,969
-108,938
-50% -$32K
OYST
4259
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$12K ﹤0.01%
2,761
– –
MILE
4260
DELISTED
Metromile, Inc. Common Stock
MILE
$12K ﹤0.01%
+13,145
New +$13.4K
CTXR icon
4261
Citius Pharmaceuticals
CTXR
$18.7M
$11K ﹤0.01%
+461
New +$12.6K
FRSX
4262
Foresight Autonomous Holdings
FRSX
$3.64M
$11K ﹤0.01%
+135
New +$13.3K
SYRS
4263
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$11K ﹤0.01%
1,128
-927
-45% -$8.67K
BYNOW
4264
DELISTED
byNordic Acquisition Corporation Warrant
BYNOW
$11K ﹤0.01%
+109,066
New +$18.3K
PNT
4265
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$11K ﹤0.01%
1,600
-32,296
-95% -$247K
MBII
4266
DELISTED
Marrone Bio Innovations, Inc.
MBII
$11K ﹤0.01%
+9,288
New +$9.71K
DRRX
4267
DELISTED
DURECT Corp
DRRX
$10K ﹤0.01%
+2,075
New +$9.91K
GLDG
4268
GoldMining Inc
GLDG
$219M
$10K ﹤0.01%
10,569
-21,061
-67% -$26.8K
MUX icon
4269
McEwen Inc
MUX
$1.18B
$10K ﹤0.01%
+2,300
New +$14.3K
NGNE icon
4270
Neurogene
NGNE
$712M
$10K ﹤0.01%
469
-1,246
-73% -$30.4K
PRCH icon
4271
Porch Group
PRCH
$1.8B
$10K ﹤0.01%
4,039
-167,559
-98% -$693K
AACIW
4272
DELISTED
Armada Acquisition Corp. I Warrant
AACIW
$10K ﹤0.01%
35,253
-19,670
-36% -$5.23K
NETI
4273
DELISTED
Eneti Inc.
NETI
$10K ﹤0.01%
1,702
-48,210
-97% -$309K
CRBU icon
4274
Caribou Biosciences
CRBU
$164M
$9K ﹤0.01%
1,747
-105,772
-98% -$809K
HLVX
4275
DELISTED
HilleVax
HLVX
$9K ﹤0.01%
+800
New +$9.5K
169 170
171
172 173

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q2 2022 Portfolio in Review

As of Q2 2022, Cubist Systematic Strategies held 4,763 positions worth $16.4B, up 38% from $11.8B the previous quarter. Its ten largest holdings account for 3% of the portfolio.

Cubist Systematic Strategies deployed $7.45B of net new capital in Q2 2022, opening 1,229 new positions and adding to 1,758 existing holdings. Its largest new stake was Sierra Lake Acquisition Corp. Class A Common Stock: 1,393,075 shares worth $13.8M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Verizon, an estimated $43.1M trimmed.

  • Cubist Systematic Strategies's largest Q2 2022 buy was Sierra Lake Acquisition Corp. Class A Common Stock: 1,393,075 shares worth $13.8M.
  • Cubist Systematic Strategies added most to American Express in Q2 2022, an estimated $71M increase.
  • Cubist Systematic Strategies's biggest Q2 2022 reduction was Verizon, cutting an estimated $43.1M.
  • Cubist Systematic Strategies fully exited UnitedHealth in Q2 2022, selling an estimated $17.1M.
  • Cubist Systematic Strategies's ten largest holdings make up 3% of its $16.4B portfolio in Q2 2022.
  • Cubist Systematic Strategies opened 1,229 new positions and closed 428 in Q2 2022.
  • Cubist Systematic Strategies's portfolio value rose 38% quarter-over-quarter to $16.4B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.